5.5 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
5.5 antibody; Fusion protein 5.5/5.7 antibody
Target Names
5.5
Uniprot No.

Q&A

What are the spectral characteristics of PerCP-Cy5.5 and how do they influence flow cytometry panel design?

PerCP-Cy5.5 is a tandem fluorophore with excitation maxima at 482 nm and 564 nm and emission maximum at approximately 695 nm. This makes it compatible with standard 488 nm blue laser excitation in flow cytometers . When designing multiparameter panels, it's important to consider that:

  • PerCP-Cy5.5 can be used alongside FITC and PE-labeled reagents with minimal spectral overlap

  • Signal capture typically occurs using a 695/40 nm bandpass filter

  • The tandem structure means energy transfer occurs from the donor molecule (PerCP) to the acceptor (Cy5.5)

  • Panel design should account for potential spillover spreading into adjacent channels, particularly when using higher antibody concentrations

What is the underlying mechanism of PerCP-Cy5.5 conjugation to antibodies?

The conjugation process for PerCP-Cy5.5 to antibodies involves several critical steps:

  • Purification of the antibody to remove interfering substances

  • Activation of the tandem dye complex consisting of Peridinin-Chlorophyll Protein (PerCP) conjugated to Cyanine 5.5

  • Formation of directional covalent bonds between the activated dye and the antibody under optimized conditions (typically pH 6.5-8.5)

  • Removal of unconjugated antibody and free fluorochrome through size-exclusion chromatography

This process preserves antibody functionality while enabling fluorescent detection. For laboratory-based conjugations, the LYNX Rapid Conjugation Kit system enables conjugation under near-neutral pH conditions, providing high conjugation efficiency and 100% antibody recovery .

How does the performance of PerCP-Cy5.5 compare with other tandem dyes in the same spectral region?

While PerCP-Cy5.5 offers improved stability and signal intensity over PerCP alone, researchers should be aware of newer alternatives that may provide superior performance:

  • RealBlue 705 (BD Biosciences)

  • NovaFluor Blue 690

  • PerCP-eFluor™ 710

These alternatives may offer better brightness, stability, or reduced spillover depending on the experimental context. The choice between these options should be guided by the specific requirements of the experiment and the configuration of available instrumentation.

What is the optimal method for titrating PerCP-Cy5.5 antibodies to minimize spillover spreading while maintaining sensitivity?

A systematic titration approach is essential for optimizing PerCP-Cy5.5 antibody performance:

  • Begin with the manufacturer's recommended concentration

  • Perform serial 2-fold dilutions of the antibody

  • Calculate the stain index (SI) for each dilution using the formula:
    SI=MeanpositiveMeannegative2×SDnegativeSI = \frac{Mean_{positive} - Mean_{negative}}{2 \times SD_{negative}}

  • Plot the SI against antibody concentration

  • Identify both the separating concentration (optimal for population discrimination) and the saturating concentration (maximum signal)

The choice between separating and saturating concentrations depends on your research goals:

  • Separating concentration: Provides good positive/negative discrimination, reduces spillover spreading, and conserves reagent

  • Saturating concentration: May be necessary for detecting low-abundance antigens but can increase spillover into other channels

How can researchers mitigate the effects of sample-induced fluorescence degradation of PerCP-Cy5.5 conjugates?

PerCP-Cy5.5, like other tandem dyes, can experience degradation from various factors. To minimize this:

  • Protect samples from prolonged light exposure during all steps of preparation and storage

  • Store conjugated antibodies at 2-8°C rather than freezing

  • Use buffers without nucleophilic components that might react with the dye chemistry

  • Consider adding protein stabilizers like BSA to storage buffers

  • For whole blood applications, minimize time between staining and analysis

  • When fixation is required, validate that your fixative doesn't adversely affect the tandem dye integrity

Researchers should also conduct experimental controls to quantify any tandem dye degradation, particularly in complex matrices like whole blood or when using fixation procedures.

What are the recommended buffer conditions for optimal PerCP-Cy5.5 antibody performance?

Buffer composition significantly impacts PerCP-Cy5.5 antibody function. Optimal conditions include:

  • pH range of 6.5-8.5

  • 10-50 mM amine-free buffers (HEPES, MES, MOPS, phosphate)

  • Avoid buffers containing nucleophilic components (primary amines, thiols)

  • Low to moderate concentrations of Tris buffer (<20 mM) may be tolerated

  • Common additives like sodium azide (0.02-0.1%), EDTA, and non-buffering salts generally have minimal impact on conjugation efficiency

  • For antibody concentrations, 1 mg/ml is optimal for most applications

For direct conjugations, the molar ratio of antibody to PerCP-Cy5.5 should be 1:1 (e.g., 100 μg antibody to 100 μg PerCP-Cy5.5) to maximize conjugation efficiency while minimizing free dye .

How does the durability of PerCP-Cy5.5 antibody signals compare in longitudinal immunological studies?

Based on research examining neutralizing antibodies after COVID-19 vaccination, the durability of fluorescent signals can be affected by sample age and storage conditions. In one study examining samples 5.5 months post-immunization:

  • Neutralizing antibody titers generally decreased compared to measurements taken shortly after immunization

  • This decrease was more pronounced in individuals without prior infection history

  • The decline in signal was more evident when analyzing responses to newer viral variants

These findings suggest that researchers conducting longitudinal studies should:

  • Include time-matched controls

  • Consider the duration between sampling and analysis

  • Account for potential differential decay rates between study groups

  • Validate assay performance specifically for aged samples

What considerations are important when using computational approaches to analyze PerCP-Cy5.5 antibody binding characteristics?

Advanced computational methods can enhance understanding of antibody-antigen interactions involving PerCP-Cy5.5 labeled antibodies:

  • Antibody modeling and molecular dynamics simulations: Generate 3D structures for immune complexes by:

    • Using VH/VL sequences to create homology models

    • Refining structures with molecular dynamics simulations

    • Employing tools like PIGS server or knowledge-based algorithms like AbPredict

  • Structure prediction and validation: Multiple approaches should be considered:

    • AbodyBuilder and AbodyBuilder2 have been validated for faithfully replicating conformations within antibody structure ensembles

    • Comparing multiple prediction methods provides higher confidence in structural analyses

  • Multi-parameter evaluation: When analyzing developability profiles:

    • Both sequence-based and structure-based parameters should be assessed

    • Structure-based parameters typically show lower interdependency than sequence-based parameters

    • Species-specific differences (human vs. mouse) should be considered in comparative analyses

How can researchers optimize whole blood staining protocols for PerCP-Cy5.5 antibodies in rare cell detection applications?

Detecting rare cell populations with PerCP-Cy5.5 antibodies requires special considerations:

  • Sample preparation optimization:

    • Use anticoagulants appropriate for your target cells (heparin, K3EDTA, or K2EDTA)

    • For rare events, the RBC:mononuclear cell ratio (approximately 600:1) necessitates RBC lysis after antibody staining

    • Standard procedures use 4 μl of reagent per 100 μl of whole blood or 10^6 cells in suspension

  • Acquisition parameters:

    • Set slow event collection rates (200-500 μL/min) to improve rare event discrimination

    • Calculate the number of events required for statistical significance based on expected frequency

    • For rare populations, consider collecting ≥500,000 total events

  • Panel design for rare events:

    • Use PerCP-Cy5.5 for markers expressed at higher levels on your target population

    • Incorporate a dump channel with markers expressed on unwanted populations

    • Include lineage-defining markers conjugated to bright fluorochromes

    • Use Boolean gating strategies to enhance rare population resolution

What are the most effective validation strategies to confirm specificity of PerCP-Cy5.5 antibody binding in complex immune cell populations?

Rigorous validation is critical for ensuring reliable results with PerCP-Cy5.5 antibodies:

  • Flow cytometric validation:

    • Compare staining patterns with isotype controls (e.g., PerCP-Cy5.5 Mouse IgG1 κ for CD8 detection)

    • Analyze forward and side scatter characteristics of positive populations

    • Validate staining on well-characterized cell populations before applying to experimental samples

  • Multi-parameter validation:

    • Confirm co-expression of expected markers (e.g., CD16 PerCP-Cy5.5 with CD3 FITC to verify NK cells)

    • Use multiple antibody clones targeting different epitopes of the same molecule

    • Compare staining patterns across different sample types

  • Functional correlation:

    • Where possible, correlate marker expression with functional assays

    • For phospho-epitopes like ZAP70(pY319)/Syk(pY352), verify signal increases after appropriate stimulation

How do different fixation and permeabilization protocols affect PerCP-Cy5.5 signal intensity and stability?

The choice of fixation and permeabilization reagents can significantly impact PerCP-Cy5.5 performance:

  • Fixation effects:

    • PerCP-Cy5.5 is generally more resistant to fixation than PerCP alone

    • Aldehyde-based fixatives can cause some reduction in signal intensity

    • Duration of fixation should be optimized (typically 10-15 minutes)

    • Concentration of fixative should be validated (commonly 1-4% paraformaldehyde)

  • Permeabilization considerations:

    • Saponin-based permeabilizers are generally preferable for preserving tandem dye integrity

    • Harsh detergents can disrupt the energy transfer between PerCP and Cy5.5

    • Sequential fixation then permeabilization typically yields better results than simultaneous protocols

    • Post-permeabilization washing steps are critical for removing residual reagents

  • Protocol optimization:

    • For intracellular staining, surface markers should be labeled prior to fixation/permeabilization

    • After fixation, samples should be protected from light during subsequent steps

    • Incubation times for antibodies may need to be extended for intracellular targets

What quality control measures should be implemented when using PerCP-Cy5.5 antibodies in longitudinal clinical research studies?

Maintaining consistency in longitudinal studies requires comprehensive quality control:

  • Reagent quality control:

    • Use the same antibody lot throughout the study when possible

    • Perform lot-to-lot validation when lot changes are unavoidable

    • Store antibodies according to manufacturer recommendations (typically 2-8°C, protected from light)

    • Track antibody performance over time using standardized control samples

  • Instrument quality control:

    • Regular cytometer calibration with fluorescent beads

    • Monitoring of laser output and detector sensitivity

    • Standardized PMT voltage settings

    • Consistent application of compensation matrices

  • Process controls:

    • Include biological controls in each batch (healthy donor samples)

    • Implement standardized gating strategies

    • Use fluorescence minus one (FMO) controls for accurate gate placement

    • Calculate coefficients of variation for key populations across runs

For longitudinal clinical studies, implementing these measures helps ensure that observed changes reflect biological differences rather than technical variability.

How can computational-experimental approaches improve PerCP-Cy5.5 antibody targeting of carbohydrate antigens?

Carbohydrate antigens present unique challenges for antibody targeting. Advanced approaches combine:

  • Computational modeling:

    • Generate 3D structures using VH/VL sequences

    • Refine models through molecular dynamics simulations

    • Use specialized servers like PIGS or algorithms like AbPredict

    • Sample large conformational spaces to identify low-energy states

  • Experimental validation:

    • Compare multiple antibody variants labeled with PerCP-Cy5.5

    • Assess binding kinetics using surface plasmon resonance

    • Validate epitope specificity through competitive binding assays

    • Correlate computational predictions with experimental binding data

This combined approach enables rational design of more potent antibodies targeting complex carbohydrate antigens, potentially improving specificity and sensitivity in glycobiology research applications.

What are the latest advancements in analyzing antibody developability parameters for PerCP-Cy5.5 conjugates?

Recent biophysical cartography approaches have advanced our understanding of antibody developability:

These advances provide a foundation for understanding how conjugation with PerCP-Cy5.5 might affect antibody developability and performance in various applications.

How does long-term storage affect the performance of PerCP-Cy5.5 conjugated antibodies in complex biological matrices?

The long-term stability of PerCP-Cy5.5 antibodies is a critical consideration for longitudinal studies:

  • Storage condition effects:

    • Recommended storage is at 2-8°C, protected from light

    • Freezing should be avoided as it can disrupt the tandem dye structure

    • Buffer composition (particularly pH and protein content) significantly impacts stability

    • Sodium azide (0.02-0.1%) helps prevent microbial contamination during long-term storage

  • Matrix-specific considerations:

    • Complex biological matrices (like whole blood or tissue homogenates) can contain compounds that accelerate dye degradation

    • Higher protein content in samples may provide some protective effects against degradation

    • Oxidizing agents and extreme pH conditions should be avoided

    • Repeated freeze-thaw cycles of samples dramatically reduce signal integrity

  • Monitoring approaches:

    • Implement regular quality control checks using standardized samples

    • Track mean fluorescence intensity of positive populations over time

    • Include reference standards in each analytical batch

    • Document lot numbers and preparation dates for all reagents

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.